Publication | Open Access

NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma

Surgical OncologyHigh-risk Intrahepatic CholangiocarcinomaGastrointestinal OncologyMedicineHepatobiliary TumorBiliary CancerNeoadjuvant GemcitabineCancer TreatmentOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences